Cathepsin E as a potent anticancer protease

Tomoyo Kawakubo, Atsushi Yasukochi, Seiji Nakamura, Kenji Yamamoto

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)


Cathepsin E (CatE), an endolysosomal aspartic protease, is predominantly expressed in cells of the immune system, and CatE-deficient mice exhibit phenotypes affecting immune responses; however, the precise role of this enzyme remains speculative. In this review, some of the knowledge obtained from a study of CatE functions in host defense against tumor cells is highlighted. In vivo studies using three different genotypes of syngeneic mice (CatE-deficent, wild-type and CatE-overexpressing transgenic mice) revealed that endogenous CatE expression levels are positively associated with the extent of tumor suppression. The number of apoptotic tumor cells and tumor-infiltrating activated macrophages increased in proportion to the endogenous CatE levels. In vitro studies also demonstrated the growth arrest and apoptosis of tumor cells by CatE without affecting normal cells through the proteolytic release of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) from the cell surface. On the basis of these observations, the present review gives an account of the manifold functions of CatE in host defense against tumor cells.

Original languageEnglish
Pages (from-to)128-136
Number of pages9
Journaljournal of oral biosciences
Issue number2
Publication statusPublished - 2011

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Dentistry(all)


Dive into the research topics of 'Cathepsin E as a potent anticancer protease'. Together they form a unique fingerprint.

Cite this